SCHEMBL21430433

SCHEMBL21430433

CNCC1CCCN(C(=O)CN(C)C)C1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ITGB3 P05106 2/20 0.41
▸ ITGA2B P08514 2/20 0.41
▸ ALDH1A1 P00352 8/20 0.40
▸ JAK2 O60674 1/20 0.39
▸ JAK1 P23458 1/20 0.39
▸ JAK3 P52333 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ LMNA P02545 2/20 0.39
▸ F2R P25116 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 2/20 0.37
▸ EPHX2 P34913 1/20 0.37
▸ DPP4 P27487 1/20 0.37
▸ PREP P48147 1/20 0.37
▸ FAP Q12884 1/20 0.37
▸ POLB P06746 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23710028 0.87 ITGB3 (0.43) ITGB3ITGA2BALDH1A1JAK2JAK1
SCHEMBL24171102 0.85 ITGB3 (0.39) ITGB3ITGA2BALDH1A1JAK2JAK1
SCHEMBL24171116 0.85 ITGB3 (0.39) ITGB3ITGA2BALDH1A1JAK2JAK1
SCHEMBL24170958 0.85 ITGB3 (0.39) ITGB3ITGA2BALDH1A1JAK2JAK1
SCHEMBL22732723 0.83 MEN1 (0.42) ITGB3ITGA2BALDH1A1JAK2JAK1
SCHEMBL13783473 0.83 MEN1 (0.42) ITGB3ITGA2BALDH1A1JAK2JAK1
SCHEMBL15491224 0.83 ITGB3 (0.43) ITGB3ITGA2BALDH1A1JAK1KDM4E
SCHEMBL22732600 0.82 JAK3 (0.42) ITGB3ITGA2BALDH1A1JAK2JAK1
SCHEMBL21430657 0.82 JAK3 (0.42) ITGB3ITGA2BALDH1A1JAK2JAK1
SCHEMBL21430432 0.82 JAK3 (0.42) ITGB3ITGA2BALDH1A1JAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019185025-A1 TRIFLUOROMETHYL-SUBSTITUTED SULFONAMIDE AS BCL-2-SELECTIVE INHIBITOR 正大天晴药业集团股份有限公司 2019-10-03 — — WO disclosed
Send feedback